AFP and hepatocellular carcinoma: Accordingly, using polymeric nanoparticles loaded with AFP-siRNA and combined with sunitinib could be a promising alternative strategy to enhance the potential of HCC treatment by alleviating the toxicity and therapeutic drug dose.